CHART, page-9

Charts

Companies comparable to AT1- GSS, UBI, LDX, all finding it tough going at the moment.
Check their charts, similar trajectory. In essence all of these companies have the same or similar issues
I think it will come back eventually to around .25

Downside
Being rap*d by freight and logistics.
Regulatory hurdles ( Au self test ) and uncertainty ( US Febridx when? ) Swab test, what is it? How, Why?
Bias against small caps generally
Covid test future uncertain

Possibilities
Opportunity in POC and self-test market in US quite big
Huge expansion because of Covid and people getting used to self-test
In the case of AT1, some good investors ( Canadian Govt, Walker, etc )
HIV is a problem that will not go away. UN has no choice but to try and stem the flow.